This is not in agreement with Ma S. study where CamKIINβ, an endogenous inhibitor of CamKII was found to down-regulate AKT (Ser 473) expression in HO-8910PM ovarian cancer cells. This evidence concerns the gene AKT1 and ovarian carcinoma.